openPR Logo
Press release

Drug and Gene Delivery Devices Market Growth Opportunities and Forecast Comprehensive Analysis of Market Trends and Growth 2024 - 2031 |Pfizer, Inc., Novartis AG, Kite Pharma

09-26-2024 11:39 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Drug and Gene Delivery Devices Market

Drug and Gene Delivery Devices Market

Global Drug and Gene Delivery Devices Market was valued at US$ 152.2 Thousand in 2022 and is forecast to reach a value of US$ 364.9 Thousand by 2030 at a CAGR of 11.6% between 2023 and 2030

The Latest study titled Drug and Gene Delivery Devices Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report highlights effective strategies and opportunities within the market, providing essential guidance for industry professionals, policymakers, stakeholders, investors, and newcomers. This will help them identify key strategies, explore market size opportunities, and gain a competitive advantage in the Drug and Gene Delivery Devices Market.

The primary aim of the report is to provide readers with a comprehensive analysis of the market, enabling them to develop effective business growth strategies, evaluate the competitive landscape, assess their current market position, and make informed business decisions related to the Drug and Gene Delivery Devices market. The report offers key projections on critical factors such as market size, production, revenue, consumption, CAGR, gross margin, and pricing. It is based on the most reliable primary and secondary research methods and resources available. Additionally, the report encompasses a variety of research studies, including analyses of market dynamics, pricing, production and consumption, company profiles, and manufacturing costs.

💡Click Here to Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/5864

*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.

Market Scope:

A key focus of the report is the comprehensive segmentation of the Drug and Gene Delivery Devices market, which includes product types, applications, end-user markets, major geographic regions, and leading market competitors. The report offers unbiased expert insights into the current market conditions, past performance, production and consumption trends, supply and demand ratios, and revenue forecasts for the projected period.

The financial standings of key players, including gross profits, sales volumes, revenue, manufacturing costs, and other financial ratios, are accurately assessed. Additionally, analytical tools such as investment evaluation, SWOT analysis, and Porter's Five Forces analysis have been employed to examine the production and distribution capabilities of market participants.

The report also features a dedicated section on major players, where our analysts provide an in-depth review of their financial statements, product benchmarking, and SWOT analysis. The competitive landscape section further covers key development strategies, market share, and ranking analysis of these players globally.

Following are the players analyzed in the report:

◘ Pfizer Inc.
◘ Novartis AG
◘ Kite Pharma Inc.
◘ Bluebird bio Inc.
◘ Becton Dickinson and Company
◘ Amgen Inc.
◘ Vericel Corporation
◘ uniQure N.V.
◘ Spark Therapeutics Inc.
◘ Renova Therapeutics
◘ Orchard Therapeutics plc
◘ Kolon Tissue Gene Inc.
◘ Human Stem Cell Institute
◘ Dendreon Pharmaceuticals
◘ Helixmith Co.Ltd
◘ (ViroMed Co. Ltd),
◘ Bausch & Lomb Incorporated
◘ Castle Creek Biosciences Inc
◘ (Fibrocell Technologies Inc.)
◘ among others.

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR):

✦ By Product :Sub-retinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-filled Syringe, and Infusion Bags
✦ By Commercialized Drugs: Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug Delivery Devices), Provenge (Drug Delivery Devices), and Strimvelis (Drug Delivery Devices)

The report will also highlight the major companies in the market, detailing their product portfolios, market shares, financial health, regional presence, segment revenues, and SWOT analyses. It will cover key strategies such as mergers and acquisitions, product innovations, joint ventures, partnerships, and expansions, along with their most recent news. Additionally, the study will include a list of emerging players in the Drug and Gene Delivery Devices s market.

✅Purchase This Premium Research Report and Get Upto 25% Discount at : https://www.coherentmarketinsights.com/insight/buy-now/5864

Deep-dive Analysis:

The Report provides deep-dive qualitative and quantitative analysis on Drug and Gene Delivery Devices Market for all the regions and countries covered below:

• North America (the United States, Canada, and Mexico)
• Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
• Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
• South America (Brazil, Argentina, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
• Each Country is covered in detail, and report provides qualitative and quantitative analysis on Drug and Gene Delivery Devices Market on each country.

Highlights of Our Report:

⏩Extensive Market Analysis: A deep dive into the manufacturing capabilities, production volumes, and technological innovations within the Drug and Gene Delivery Devices Market.

⏩ Corporate Insights: An in-depth review of company profiles, spotlighting major players and their strategic manoeuvres in the market's competitive arena.

⏩Consumption Trends: A detailed analysis of consumption patterns, offering insight into current demand dynamics and consumer preferences.

⏩Segmentation Details: An exhaustive breakdown of end-user segments, depicting the market's spread across various applications and industries.

⏩ Pricing Evaluation: A study of pricing structures and the elements influencing market pricing strategies.

⏩ Future Outlook: Predictive insights into market trends, growth prospects, and potential challenges ahead.

Reason to Buy this Report:

■ Study of the impact of technological developments on the market and the emerging trends shaping the industry in the coming years.
■ Analysis of the regulatory and policy changes affecting the market and the effects of these changes for market participants.
■ Summary of the competitive landscape in the Drug and Gene Delivery Devices market, including profiles of the key players, their market share, and strategies for growth.
■Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■Assessment of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.

✅Purchase This Premium Research Report and Get Upto 25% Discount at : https://www.coherentmarketinsights.com/insight/buy-now/5864

Questions Answered by the Report:

(1) Which are the dominant players of the Drug and Gene Delivery Devices Market?
(2) What will be the size of the Drug and Gene Delivery Devices Market in the coming years?
(3) Which segment will lead the Drug and Gene Delivery Devices Market?
(4) How will the market development trends change in the next five years?
(5) What is the nature of the competitive landscape of the Drug and Gene Delivery Devices Market?
(6) What are the go-to strategies adopted in the Drug and Gene Delivery Devices Market?

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

☎ Contact Us:

Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug and Gene Delivery Devices Market Growth Opportunities and Forecast Comprehensive Analysis of Market Trends and Growth 2024 - 2031 |Pfizer, Inc., Novartis AG, Kite Pharma here

News-ID: 3668840 • Views:

More Releases from Coherent Market Insights

Genetic Chronic Obstructive Pulmonary Disease (COPD) Market Industry Insights: Market Size, Share, and Growth Forecast 2024 - 2031 |GSK Plc, AstraZeneca Plc, Merck (Sigma-Aldrich), Dey Pharma
Genetic Chronic Obstructive Pulmonary Disease (COPD) Market Industry Insights: M …
Genetic Chronic Obstructive Pulmonary Disease (COPD) Market High Growth Opportunities, Emerging Trends, Forecast Till 2031 |GSK Plc, AstraZeneca Plc, Merck (Sigma-Aldrich), Dey Pharma The Latest study titled Genetic Chronic Obstructive Pulmonary Disease (COPD) Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis,
PD-1 and PD-L1 Inhibitor Market Set To Experience Rapid Growth From 2024 to 2031: Pfizer Inc., Novartis AG, AstraZeneca PLC, Gilead Sciences Inc., Amgen Inc
PD-1 and PD-L1 Inhibitor Market Set To Experience Rapid Growth From 2024 to 2031 …
The PD-1 and PD-L1 inhibitor market is estimated to be valued at USD 52.51 Bn in 2024 and is expected to reach USD 170.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.3% from 2024 to 2031. Latest Report, titled "PD-1 and PD-L1 Inhibitor Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights
Epinephrine Autoinjector Market Generated Opportunities, Future Scope 2024-2031 | Mylan, Teva Pharmaceutical, Impax Laboratories, Adamis Pharmaceuticals Corporation
Epinephrine Autoinjector Market Generated Opportunities, Future Scope 2024-2031 …
Latest Report, titled "Epinephrine Autoinjector Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Epinephrine Autoinjector market has been expanding significantly
Medical Probiotics Market Is Booming Worldwide 2024-2031 | DowDuPont Inc., Kerry Group plc., BioGaia AB, DSM, Sun Genomics
Medical Probiotics Market Is Booming Worldwide 2024-2031 | DowDuPont Inc., Kerry …
Latest Report, titled "Medical Probiotics Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Medical Probiotics market has been expanding significantly

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug